Showing results (31-40 of 366) with videos related to
Sort By:
Pageof 37
Pharmacotherapy|March 20, 2014
Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approvalKevin W McConeghy, Adam Bress, Dima M Qato, et al.AIDS and Behavior|January 15, 2020
Adherence to Antiretroviral Therapy Among HIV Patients in India: A Systematic Review and Meta-analysisApurba Chakraborty, Ronald C Hershow, Dima M Qato, et al.AIDS (London, England)|October 1, 2019
Antiretroviral therapy adherence among treatment-naive HIV-infected patientsApurba Chakraborty, Dima M Qato, Saria S Awadalla, et al.Health Affairs (Project Hope)|November 5, 2014
'Pharmacy deserts' are prevalent in Chicago's predominantly minority communities, raising medication access concernsDima M Qato, Martha L Daviglus, Jocelyn Wilder, et al.Journal of Epidemiology and Community Health|October 17, 2018
Consumer credit, chronic disease and risk behavioursLorraine T Dean, Emily A Knapp, Sevly Snguon, et al.Journal of the American Heart Association|February 23, 2024
Association Between Pharmacy Proximity With Cardiovascular Medication Use and Risk Factor Control in the United StatesAlexander R Zheutlin, Nasser Sharareh, Jenny S Guadamuz, et al.Journal of the American Pharmacists Association : Japha|January 12, 2024
Access to community pharmacies based on drive time and by rurality across the contiguous United StatesNasser Sharareh, Alexander R Zheutlin, Dima M Qato, et al.Health Services Research|September 8, 2009
Impact of family structure on stimulant use among children with attention-deficit/hyperactivity disorderAtonu Rabbani, G Caleb AlexanderAmerican Journal of Hypertension|April 26, 2008
Out-of-pocket and total costs of fixed-dose combination antihypertensives and their componentsAtonu Rabbani, G Caleb AlexanderClinical Pharmacology in Drug Development|February 2, 2019
Use of Population Pharmacokinetic Analyses Among FDA-Approved BiologicsKen Ogasawara, G Caleb AlexanderPageof 37